等待開盤 11-04 09:30:00 美东时间
+13.310
+5.99%
今日重点评级关注:富瑞:维持ArriVent BioPharma"买入"评级,目标价从18美元升至30美元;古根海姆:维持第一太阳能"买入"评级,目标价从282美元升至299美元
10-28 12:30
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James analyst Melissa Fairbanks upgraded MACOM Technology Solutions Holdings, Inc. (NASDA...
10-27 21:25
MACOM Technology Solutions Holdings, Inc. (MACOM) plans to announce its fourth quarter and fiscal year 2026 financial results on November 5, 2026, before the market open. The company will host a conference call at 8:30 a.m. Eastern Time, led by President and CEO Stephen G. Daly and CFO John F. Kober. Investors can register for a live call access code or watch the webcast via MACOM’s Investor Relations website. A replay will be available within 24...
10-22 12:30
MACOM Technology Solns (NASDAQ:MTSI) has outperformed the market over the past 10 years by 8.75% on an annualized basis producing an average annual return of 22.52%. Currently, MACOM Technology Solns has a market capitalization of $23.40 billion. Buying $100 In MTSI: If an investor had bought $100 o...
10-14 00:00
• 分析师的正面评价与估值回调推动了强劲的买盘需求。 • 下一代光芯片组将增长动能与持续扩张的 AI 基础设施深度绑定。 • 强劲的利润率与低债务水平为机构投资者的信心提供了支撑。
10-06 19:16
MACOM Technology Solns (NASDAQ:MTSI) has outperformed the market over the past 5 years by 21.63% on an annualized basis producing an average annual return of 33.64%. Currently, MACOM Technology Solns has a market capitalization of $21.27 billion. Buying $1000 In MTSI: If an investor had bought $1000...
09-29 04:45
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst David George upgraded Regions Financial Corp (NYSE:RF) from Underperform to Neutral...
09-18 20:49
BMO Capital analyst Harsh Kumar upgrades MACOM Technology Solns (NASDAQ:MTSI) from Market Perform to Outperform and maintains the price target from $335 to $335.
09-18 17:54
Source: TradePulse | September 09, 2026 Market Overview Recent aggregate flow data reflects continued participation across several key market segments, with technology, semiconductors, healthcare, financial services, consumer, industrial technology, and ETFs represented within TradePulse’s Top Inflo...
09-10 03:00